Publication | Closed Access

Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

Percutaneous Coronary InterventionThrombosisMonth 12Cardiovascular DiseaseCoronary Artery DiseasePlatelet AntagonistPharmacotherapyAcute Myocardial InfarctionVersus TicagrelorPublic HealthMedicineAnticoagulantCardiologyAcute Coronary SyndromesEmergency MedicineAnesthesiology